NBCNews.com |
'Intriguing': 9 Weeks of Trastuzumab for Breast Cancer
Medscape SAN ANTONIO ― Nine weeks of treatment with trastuzumab (multiple brands) fell short of being noninferior to 1 year of treatment in a randomized controlled trial in early-stage HER2-positive breast cancer, according to findings reported here at the San ... Are 3-D mammograms really better? US puts scans to the test Study to Determine if 3-D Mammograms Produce Better Results Here's a Promising Way to Treat Pain in Breast Cancer Treatment |
from Health - Google News http://ift.tt/2nG2B7y
EmoticonEmoticon